Azithromycin: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: In medicine, '''azithromycin''' is a "semi-synthetic macrolide antibiotic structurally related to erythromycin. It has been used in the treatment of [[Mycobacterium avium intra...) |
imported>Robert Badgett |
||
| Line 2: | Line 2: | ||
==Development== | ==Development== | ||
Azithromycin was [[patent]]ed in 1982.<ref name="urlpatent:4328334 - Google Patents">{{cite web |url=http://www.google.com/patents?q=patent:4328334 |title=patent:4328334 - Google Patents |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.<ref name="urlDrugs@FDA">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=ZITHROMAX |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Non-authorized | Azithromycin was [[patent]]ed in 1982.<ref name="urlpatent:4328334 - Google Patents">{{cite web |url=http://www.google.com/patents?q=patent:4328334 |title=patent:4328334 - Google Patents |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.<ref name="urlDrugs@FDA">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=ZITHROMAX |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Non-authorized [[generic drug]]s manufactured by [http://www.tevapharm.com/ Teva], [http://www.sandoz.com/ Sandoz], and Abraxis were approved in the [[United States]] starting in 2005.<ref name="urlDrugs@FDA">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=azithromycin |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 00:50, 2 February 2009
In medicine, azithromycin is a "semi-synthetic macrolide antibiotic structurally related to erythromycin. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis."[1]
Development
Azithromycin was patented in 1982.[2] Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.[3] Non-authorized generic drugs manufactured by Teva, Sandoz, and Abraxis were approved in the United States starting in 2005.[3]
References
- ↑ Anonymous (2024), Azithromycin (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ patent:4328334 - Google Patents. Retrieved on 2009-02-01.
- ↑ 3.0 3.1 Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01. Cite error: Invalid
<ref>tag; name "urlDrugs@FDA" defined multiple times with different content